Pharmaceutics 2011, 3(2), 141-170; doi:10.3390/pharmaceutics3020141
Review

Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery

1 Advanced Science & Technology Laboratory, AstraZeneca R&D Charnwood, Loughborough LE11 5RH, UK 2 Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK 3 Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XR, UK
* Author to whom correspondence should be addressed.
Received: 14 February 2011; in revised form: 21 March 2011 / Accepted: 31 March 2011 / Published: 4 April 2011
(This article belongs to the Special Issue Drug Discovery Tools)
PDF Full-text Download PDF Full-Text [2094 KB, Updated Version, uploaded 6 April 2011 08:24 CEST]
The original version is still available [6253 KB, uploaded 4 April 2011 09:24 CEST]
Abstract: Dynamic regulation of specific molecular processes and cellular phenotypes in live cell systems reveal unique insights into cell fate and drug pharmacology that are not gained from traditional fixed endpoint assays. Recent advances in microscopic imaging platform technology combined with the development of novel optical biosensors and sophisticated image analysis solutions have increased the scope of live cell imaging applications in drug discovery. We highlight recent literature examples where live cell imaging has uncovered novel insight into biological mechanism or drug mode-of-action. We survey distinct types of optical biosensors and associated analytical methods for monitoring molecular dynamics, in vitro and in vivo. We describe the recent expansion of live cell imaging into automated target validation and drug screening activities through the development of dedicated brightfield and fluorescence kinetic imaging platforms. We provide specific examples of how temporal profiling of phenotypic response signatures using such kinetic imaging platforms can increase the value of in vitro high-content screening. Finally, we offer a prospective view of how further application and development of live cell imaging technology and reagents can accelerate preclinical lead optimization cycles and enhance the in vitro to in vivo translation of drug candidates.
Keywords: imaging; intravital; high-content; temporal; fluorescence; drug discovery; biomarkers; translation; efficacy

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Isherwood, B.; Timpson, P.; McGhee, E.J.; Anderson, K.I.; Canel, M.; Serrels, A.; Brunton, V.G.; Carragher, N.O. Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery. Pharmaceutics 2011, 3, 141-170.

AMA Style

Isherwood B, Timpson P, McGhee EJ, Anderson KI, Canel M, Serrels A, Brunton VG, Carragher NO. Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery. Pharmaceutics. 2011; 3(2):141-170.

Chicago/Turabian Style

Isherwood, Beverley; Timpson, Paul; McGhee, Ewan J; Anderson, Kurt I; Canel, Marta; Serrels, Alan; Brunton, Valerie G; Carragher, Neil O. 2011. "Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery." Pharmaceutics 3, no. 2: 141-170.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert